ALNY

Alnylam Pharmaceuticals, Inc. News Headlines

$109.07
*  
4.17
3.98%
Get ALNY Alerts
*Delayed - data as of Aug. 28, 2015  -  Find a broker to begin trading ALNY now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    ALNY After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By





What Are IBB and XBI’s Valuations?
8/25/2015 9:17:00 AM - Market Realist


What Are IBB and XBI’s Valuations?
8/25/2015 8:12:00 AM - Market Realist


IBB Outperforms XBI: Top 10 Mid-Cap Stocks
8/21/2015 11:08:00 PM - Market Realist


What Are IBB and XBI’s Valuations?
8/20/2015 6:52:00 PM - Market Realist


IBB and XBI Underperformed the Benchmark Indexes
8/20/2015 6:51:00 PM - Market Realist


Alnylam Pharmaceuticals Underperformed: Fell by 16%
8/20/2015 10:06:00 AM - Market Realist


Regeneron Leads and Shire Dragged the Large-Cap Stocks
8/19/2015 9:07:00 AM - Market Realist


IBB Drops Out of the 50-Day and 20-Day Moving Averages
8/18/2015 2:56:00 PM - Market Realist


IBB Fell by 3.62% in the Week Ending August 7
8/18/2015 2:56:00 PM - Market Realist


Unpartnered Assets Face Waiting Game
8/18/2015 9:46:00 AM - Seeking Alpha




















Alnylam initiates Phase 1/2 ALN-AAT trial in liver disease
7/27/2015 11:05:00 AM - Seeking Alpha






An Assessment Of Celgene's Deal For Receptos
7/21/2015 12:46:00 PM - Seeking Alpha